Regencell Bioscience HoldingRGC
13F holders, Q2 2025 (June 30)14holders +9
11new positions
2sold out
$17.04avg. 13F price*
At the end of Q2 2025, 14 institutions reported holding Regencell Bioscience Holding (RGC) in their 13F filings, up 9 from Q1 2025. 11 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($6.7M), Squarepoint Ops LLC ($1.7M) and Schonfeld Strategic Advisors LLC ($888K).
- Company
- Regencell Bioscience Holding
- CUSIP
- G7487R100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $4.4M |
| Exits | 2 | $52K |
All 13F filers, Q1 2025 → Q2 2025: 684,534 shares bought and 1,646 shares sold, net +682,888 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Geode Capital Management, LLC | 0.00% | Add +5637.5% | 391,066 | $6.7M |
| Squarepoint Ops LLC | 0.00% | New | 99,843 | $1.7M |
| Schonfeld Strategic Advisors LLC | 0.01% | New | 52,100 | $888K |
| BNP Paribas Financial Markets | 0.00% | New | 45,050 | $768K |
| UBS Group AG | 0.00% | New | 37,527 | $639K |
| Morgan Stanley | 0.00% | Add +660300.0% | 33,020 | $563K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | New | 13,042 | $222K |
| Greenfield Savings Bank | 0.09% | New | 11,000 | $187K |
| BlackRock, Inc. | 0.00% | Add +2266.1% | 8,589 | $146K |
| Osaic Holdings, Inc. | 0.00% | New | 190 | $3K |
| Bank of America Corp. | 0.00% | New | 100 | $2K |
| Raymond James Financial Inc. | 0.00% | New | 71 | $1K |
| Citigroup Inc. | 0.00% | New | 70 | $1K |
| Farther Finance Advisors, LLC | 0.00% | New | 50 | $852 |
"% of holder's portfolio" is RGC's weight in each manager's 13F, not the share of Regencell Bioscience Holding the manager owns.